- Interesting Late Stage Viral Vaccine CandidatesPosted 14 days ago
- From Product Candidate to Product: The Road to Commercialization in Regenerative MedicinePosted 36 days ago
- Part III – Fifteen Cell Therapies/Stem Cell Therapies in Phase III Clinical TrialsPosted 42 days ago
- Part II – Fifteen Cell Therapies/Stem Cell Therapies in Phase III Clinical TrialsPosted 50 days ago
- Fifteen Cell and Stem Cell Therapies in Phase III Clinical Trials – Part IPosted 56 days ago
- Biologics Have a Robust Pipeline According to Latest PhRMA ReportPosted 63 days ago
- Biologics Take Top Spots in Best Selling Drugs of 2012Posted 70 days ago
- Best Practices in Cell Therapy ManufacturingPosted 106 days ago
- Can Stable Expression Levels be Achieved in a Transient Expression System – Expi293Posted 119 days ago
- Identifying Options for Stem Cell Based Therapy Scale-upPosted 137 days ago
The Top 12 Cell Culture Dish Blogs of 2012
To cap off this year, I have compiled a list of our top 12 Cell Culture Dish blogs for 2012. I hope you enjoy a few that you may have missed during the year. Happy New Year!...
- Posted December 31, 2012
The Dish’s Weekly News Wrap Up – December 28, 2012
This week’s headlines include, possible Thimerosal ban threatens vaccinations for the world’s poor, market strategy options for start up biotech companies, stem cells studied as a possible treatment option for ALS, Amgen licenses ImmunoGen’s TAP Technology, and...
- Posted December 28, 2012
The Dish’s Weekly News Wrap Up – December 21, 2012
This week’s headlines include, new drug approvals, best biotech CEO of 2012, whole genome sequencing and gene patents, focus on treatment for ALS, and pediatricians change their position on Thimerosal. Happy Holidays: Happy Holidays from The Cell...
- Posted December 21, 2012
Novel ECM Mimetic Surfaces for Cell Expansion and Differentiation
Corning Life Sciences ASCB December 17, 2012 Marshall Kosovsky, Ph.D., Technical Support Manager
- Posted December 17, 2012
The Dish’s Weekly News Wrap Up – December 14, 2012
This week’s headlines include, upcoming stem cell trial without embryo destruction, fiscal cliff could create problems for biotechs, Britain launches genome database, global pediatric market on the rise, and experimental therapy helps girl beat leukemia. Headlines: “Stem-Cell...
- Posted December 14, 2012